|
Home : Unsafe Drugs : Avandia : Newsfeeds : GlaxoSmithKline hit by cuts to spending GlaxoSmithKline hit by cuts to spending
In the fourth quarter of 2010, Glaxo clocked up a rare loss following a £2.2bn legal hit linked to its Avandia drug. Savings from a swingeing costcutting programme and disposals helped to offset a 10% drop in its revenues compared to a year ago.
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




